Cramer Holger, Lauche Romy, Klose Petra, Lange Silke, Langhorst Jost, Dobos Gustav J
Department of Internal and Integrative Medicine, Kliniken Essen-Mitte, Faculty of Medicine, University of Duisburg-Essen, Am Deimelsberg 34a, Essen, Germany, 45276.
Australian Research Centre in Complementary and Integrative Medicine, University of Technology Sydney, 235-253 Jones Street, Ultimo, Australia, 2007.
Cochrane Database Syst Rev. 2017 Jan 3;1(1):CD010802. doi: 10.1002/14651858.CD010802.pub2.
Breast cancer is the cancer most frequently diagnosed in women worldwide. Even though survival rates are continually increasing, breast cancer is often associated with long-term psychological distress, chronic pain, fatigue and impaired quality of life. Yoga comprises advice for an ethical lifestyle, spiritual practice, physical activity, breathing exercises and meditation. It is a complementary therapy that is commonly recommended for breast cancer-related impairments and has been shown to improve physical and mental health in people with different cancer types.
To assess effects of yoga on health-related quality of life, mental health and cancer-related symptoms among women with a diagnosis of breast cancer who are receiving active treatment or have completed treatment.
We searched the Cochrane Breast Cancer Specialised Register, MEDLINE (via PubMed), Embase, the Cochrane Central Register of Controlled Trials (CENTRAL; 2016, Issue 1), Indexing of Indian Medical Journals (IndMED), the World Health Organization (WHO) International Clinical Trials Registry Platform (ICTRP) search portal and Clinicaltrials.gov on 29 January 2016. We also searched reference lists of identified relevant trials or reviews, as well as conference proceedings of the International Congress on Complementary Medicine Research (ICCMR), the European Congress for Integrative Medicine (ECIM) and the American Society of Clinical Oncology (ASCO). We applied no language restrictions.
Randomised controlled trials were eligible when they (1) compared yoga interventions versus no therapy or versus any other active therapy in women with a diagnosis of non-metastatic or metastatic breast cancer, and (2) assessed at least one of the primary outcomes on patient-reported instruments, including health-related quality of life, depression, anxiety, fatigue or sleep disturbances.
Two review authors independently collected data on methods and results. We expressed outcomes as standardised mean differences (SMDs) with 95% confidence intervals (CIs) and conducted random-effects model meta-analyses. We assessed potential risk of publication bias through visual analysis of funnel plot symmetry and heterogeneity between studies by using the Chi test and the I statistic. We conducted subgroup analyses for current treatment status, time since diagnosis, stage of cancer and type of yoga intervention.
We included 24 studies with a total of 2166 participants, 23 of which provided data for meta-analysis. Thirteen studies had low risk of selection bias, five studies reported adequate blinding of outcome assessment and 15 studies had low risk of attrition bias.Seventeen studies that compared yoga versus no therapy provided moderate-quality evidence showing that yoga improved health-related quality of life (pooled SMD 0.22, 95% CI 0.04 to 0.40; 10 studies, 675 participants), reduced fatigue (pooled SMD -0.48, 95% CI -0.75 to -0.20; 11 studies, 883 participants) and reduced sleep disturbances in the short term (pooled SMD -0.25, 95% CI -0.40 to -0.09; six studies, 657 participants). The funnel plot for health-related quality of life was asymmetrical, favouring no therapy, and the funnel plot for fatigue was roughly symmetrical. This hints at overall low risk of publication bias. Yoga did not appear to reduce depression (pooled SMD -0.13, 95% CI -0.31 to 0.05; seven studies, 496 participants; low-quality evidence) or anxiety (pooled SMD -0.53, 95% CI -1.10 to 0.04; six studies, 346 participants; very low-quality evidence) in the short term and had no medium-term effects on health-related quality of life (pooled SMD 0.10, 95% CI -0.23 to 0.42; two studies, 146 participants; low-quality evidence) or fatigue (pooled SMD -0.04, 95% CI -0.36 to 0.29; two studies, 146 participants; low-quality evidence). Investigators reported no serious adverse events.Four studies that compared yoga versus psychosocial/educational interventions provided moderate-quality evidence indicating that yoga can reduce depression (pooled SMD -2.29, 95% CI -3.97 to -0.61; four studies, 226 participants), anxiety (pooled SMD -2.21, 95% CI -3.90 to -0.52; three studies, 195 participants) and fatigue (pooled SMD -0.90, 95% CI -1.31 to -0.50; two studies, 106 participants) in the short term. Very low-quality evidence showed no short-term effects on health-related quality of life (pooled SMD 0.81, 95% CI -0.50 to 2.12; two studies, 153 participants) or sleep disturbances (pooled SMD -0.21, 95% CI -0.76 to 0.34; two studies, 119 participants). No trial adequately reported safety-related data.Three studies that compared yoga versus exercise presented very low-quality evidence showing no short-term effects on health-related quality of life (pooled SMD -0.04, 95% CI -0.30 to 0.23; three studies, 233 participants) or fatigue (pooled SMD -0.21, 95% CI -0.66 to 0.25; three studies, 233 participants); no trial provided safety-related data.
AUTHORS' CONCLUSIONS: Moderate-quality evidence supports the recommendation of yoga as a supportive intervention for improving health-related quality of life and reducing fatigue and sleep disturbances when compared with no therapy, as well as for reducing depression, anxiety and fatigue, when compared with psychosocial/educational interventions. Very low-quality evidence suggests that yoga might be as effective as other exercise interventions and might be used as an alternative to other exercise programmes.
乳腺癌是全球女性中最常被诊断出的癌症。尽管生存率在不断提高,但乳腺癌常伴有长期的心理困扰、慢性疼痛、疲劳和生活质量受损。瑜伽包含了关于道德生活方式、精神修行、体育活动、呼吸练习和冥想的建议。它是一种辅助疗法,通常被推荐用于治疗与乳腺癌相关的损伤,并且已被证明能改善不同癌症类型患者的身心健康。
评估瑜伽对正在接受积极治疗或已完成治疗的乳腺癌女性患者的健康相关生活质量、心理健康和癌症相关症状的影响。
我们于2016年1月29日检索了Cochrane乳腺癌专业注册库、MEDLINE(通过PubMed)、Embase、Cochrane对照试验中心注册库(CENTRAL;2016年第1期)、印度医学期刊索引(IndMED)、世界卫生组织(WHO)国际临床试验注册平台(ICTRP)搜索门户以及Clinicaltrials.gov。我们还检索了已识别的相关试验或综述的参考文献列表,以及补充医学研究国际大会(ICCMR)、欧洲综合医学大会(ECIM)和美国临床肿瘤学会(ASCO)的会议记录。我们未设语言限制。
随机对照试验符合以下条件时即为合格:(1)比较瑜伽干预与未治疗或与任何其他积极治疗对已诊断为非转移性或转移性乳腺癌女性的效果;(2)使用患者报告的工具评估至少一项主要结局,包括健康相关生活质量、抑郁、焦虑、疲劳或睡眠障碍。
两位综述作者独立收集关于方法和结果的数据。我们将结局表示为具有95%置信区间(CI)的标准化均数差(SMD),并进行随机效应模型的Meta分析。我们通过漏斗图对称性的视觉分析以及使用卡方检验和I统计量评估研究间的异质性,来评估潜在的发表偏倚风险。我们对当前治疗状态、诊断后的时间、癌症分期和瑜伽干预类型进行了亚组分析。
我们纳入了24项研究,共2166名参与者,其中23项研究提供了Meta分析的数据。13项研究的选择偏倚风险较低,5项研究报告结局评估有充分的盲法,15项研究的失访偏倚风险较低。17项比较瑜伽与未治疗的研究提供了中等质量的证据,表明瑜伽改善了健康相关生活质量(合并SMD 0.22,95%CI 0.04至0.40;10项研究,675名参与者),减轻了疲劳(合并SMD -0.48,95%CI -0.75至 -0.20;11项研究,883名参与者),并在短期内减少了睡眠障碍(合并SMD -0.25,95%CI -0.40至 -0.09;6项研究,657名参与者)。健康相关生活质量的漏斗图不对称,偏向未治疗组,而疲劳的漏斗图大致对称。这表明总体发表偏倚风险较低。瑜伽在短期内似乎并未减轻抑郁(合并SMD -0.13,95%CI -0.31至0.05;7项研究,496名参与者;低质量证据)或焦虑(合并SMD -0.53,95%CI -1.10至0.04;6项研究,346名参与者;极低质量证据),对健康相关生活质量(合并SMD 0.10,95%CI -0.23至0.42;2项研究,146名参与者;低质量证据)或疲劳(合并SMD -0.04,95%CI -0.36至0.29;2项研究,146名参与者;低质量证据)也没有中期影响。研究者报告无严重不良事件。4项比较瑜伽与心理社会/教育干预的研究提供了中等质量的证据,表明瑜伽可在短期内减轻抑郁(合并SMD -2.29,95%CI -3.97至 -0.61;4项研究,226名参与者)、焦虑(合并SMD -